Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Repotrectinib vs Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Boston, Massachusetts
This trial is testing two medications, repotrectinib and crizotinib, in patients with a specific type of lung cancer that hasn't been treated with certain drugs before. These medications work by blocking a protein that helps cancer cells grow and spread. The goal is to see if these treatments are effective and safe for these patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service